Fidelity, Arch support, RNAi emerging player City Therapeutics (CTY.US) aims for US IPO, plans to raise up to 185 millions dollars
智通财经2026/10/09 12:36According to Jinse Finance, early-stage RNAi drug developer City Therapeutics Inc. (CTY.US) is seeking to raise up to 184.7 millions USD in its U.S. initial public offering (IPO). According to documents filed with the U.S. Securities and Exchange Commission on Friday, the company, whose investors include Arch Venture Partners and Fidelity Management & Research, plans to issue 9.72 million shares at a price range of $17 to $19 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Indonesia raises the price of Minas crude oil to $115.97 per barrel in September
Indonesia has raised the September Minas crude oil price to $115.97 per barrel.
INE crude oil futures main contract drops 1.55%, quoted at 729.8 yuan/barrel
The main contract of China's INE crude oil futures has just surpassed the 730.0 yuan/barrel mark, with the latest quote at 729.8 yuan/barrel, down 1.55% intraday.
INE crude oil futures surpass 740 yuan/barrel, Shanghai fuel oil surpasses 5,100 yuan/ton
The main contract of China's INE crude oil futures has just broken through the 740.0 yuan/barrel mark, now quoted at 740.3 yuan/barrel, down 0.13% intraday; Shanghai fuel oil futures have just broken through the 5100 yuan/ton mark, now quoted at 5102 yuan/ton, up 0.35% intraday.
Gazprom and Lukoil begin production at the Layavozhskoye oil field
Gazprom and Lukoil have started production at the Rayavozhskoye oil field.
Crypto prices
More
